United States  

Trusted News Discovery Since 2008
One News Page
> > >

FDA finds small amounts of probable carcinogen in Zantac and other heartburn drugs

USATODAY.com Friday, 13 September 2019
The FDA tested ranitidine heartburn medications and found small amounts of a probable carcinogen. The agency has not recommended the drugs be recalled
0
shares
ShareTweetSavePostSend
 
Credit: Rumble - Published < > Embed
News video: FDA Finds Traces Of Probable Carcinogen In Some Heartburn Drugs

FDA Finds Traces Of Probable Carcinogen In Some Heartburn Drugs 00:58

​The FDA says Zantac-brand heartburn medicines contain small amounts of a known &quot;probable carcinogen.&quot;

Recent related videos from verified sources

New Concerns About Heartburn Drug, Chemical Linked To Cancer [Video]New Concerns About Heartburn Drug, Chemical Linked To Cancer

FDA testing has revealed some batches of Zantac and its generic versions had unacceptable levels of NDMA, a chemical linked to cancer. CBS News' Dr. John LaPook reports.

Credit: CBS 2 Chicago     Duration: 03:06Published

Zantac And Other Heartburn Drugs Linked To Cancer [Video]Zantac And Other Heartburn Drugs Linked To Cancer

Since the recall is voluntary, The FDA says some of these products might still be on shelves. Many generic brands have also been pulled.

Credit: CBS2 LA     Duration: 02:42Published

You Might Like


Tweets about this

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2020 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.